FDA Alerts
FDA: Sexual Enhancement Product Contains Hidden Drug Ingredient
The Food and Drug Administration (FDA) is advising consumers not to purchase or use Black Storm, a product promoted and sold for sexual enhancement on various websites and possibly in some retail stores.
FDA Approves Osphena for Postmenopausal Women Experiencing Pain During Sex
The US Food and Drug Administration today approved Osphena (ospemifene) to treat women experiencing moderate to severe dyspareunia (pain during sexual intercourse), a symptom of vulvar and vaginal atrophy due to menopause.
New Erectile Dysfunction Drug Stendra Approved
The U.S. Food and Drug Administration approved Stendra ( avanafil ), a new drug to treat erectile dysfunction.
FDA Recalls RegenArouse
Regeneca , Inc. notifed the public of a nationwide recall of RegenArouse , Lot Number 130100. FDA lab analysis confirmed the presence of Tadalafil , an FDA-approved drug used as treatment for male Erectile Dysfunction (ED), making this product an unapproved new drug.
Not for the Faint of Heart
Kanec USA Inc. is voluntarily recalling all lots of its male enhancement capsules due to unapproved use of an erectile dysfunction drug that could lead to potentially dangerous drug interactions.